|
|
Blood, 15 May 2007, Vol. 109, No. 10, pp. 4368-4375.
Prepublished online as a Blood First Edition Paper on January 16, 2007; DOI 10.1182/blood-2006-11-055756.
Previous Article | Next Article 
Submitted November 2, 2006
Accepted January 8, 2007
Nonredundant roles for Stat5a/b in directly regulating Foxp3
Zhengju Yao, Yuka Kanno, Marc Kerenyi, Geoffrey Stephens, Lydia Durant, Wendy T Watford, Arian Laurence, Gertraud W. Robinson, Ethan M Shevach, Richard Morrigl, Lothar Hennighausen, Changyou Wu, and John J O'Shea*
Molecular Immunology and Inflammation Branch, NIAMS/NIH, Bethesda, MD, United States
Dept of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna (MUW), Vienna, Austria
Laboratory of Immunology, NIAID/NIH, Bethesda, MD, United States
Laboratory of Genetics and Physiology, NIDDK, NIH, Bethesda, MD, United States
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Department of Immunology, Zhongshan Medical School, Sun Yat-sen University, China
* Corresponding author; email: osheajo{at}mail.nih.gov.
Stats (signal transducers and activators of transcription) regulate multiple aspects of T cell fate. T regulatory (Treg) cells are a critical subset that limits immune responses, but the relative importance of Stat5a/b versus Stat3 for Treg cell development has been contentious. We observed that peripheral CD25+CD4+ T cells were reduced in Stat5 N mice; however, the levels of Foxp3, a transcription factor that is critical for Treg cells, were normal in splenic CD4+ T cells even though they were reduced in the thymus. In contrast, complete deletion of Stat5a/b (Stat5-/-) resulted in dramatic reduction in CD25- or Foxp3-expressing CD4+ T cells. An intrinsic requirement was demonstrated by reduction of Stat5a/b in CD4-expressing cells and by stem cell transplantation using Stat5-/- fetal liver cells. Stat5a/b were also required for optimal induction of Foxp3 in vitro and bound directly to the foxp3 gene. Reduction of Stat3 in T cells did not reduce the numbers of Treg cells in the thymus or spleen; however, Stat3 was required for IL-6-dependent down-regulation of Foxp3. Therefore, we conclude that Stat5a/b have an essential, non-redundant role in regulating Treg cells and that Stat3 and Stat5a/b appear to have opposing roles in the regulation of Foxp3.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Chen, L. Fang, S. Song, T. B. Guo, A. Liu, and J. Z. Zhang
Thymic Regulation of Autoimmune Disease by Accelerated Differentiation of Foxp3+ Regulatory T Cells through IL-7 Signaling Pathway
J. Immunol.,
November 15, 2009;
183(10):
6135 - 6144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi
Regulatory T cells: how do they suppress immune responses?
Int. Immunol.,
October 1, 2009;
21(10):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shi, T. H. Lin, K. C. Appell, and L. J. Berg
Cell Cycle Progression following Naive T Cell Activation Is Independent of Jak3/Common {gamma}-Chain Cytokine Signals
J. Immunol.,
October 1, 2009;
183(7):
4493 - 4501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Wolf, K. Eller, R. Zeiser, C. Durr, U. V. Gerlach, M. Sixt, L. Markut, G. Gastl, A. R. Rosenkranz, and D. Wolf
The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
J. Immunol.,
September 15, 2009;
183(6):
3751 - 3760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Elyaman, E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J.-C. Renauld, et al.
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells
PNAS,
August 4, 2009;
106(31):
12885 - 12890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ichiyama, M. Hashimoto, T. Sekiya, R. Nakagawa, Y. Wakabayashi, Y. Sugiyama, K. Komai, I. Saba, T. Moroy, and A. Yoshimura
Gfi1 negatively regulates Th17 differentiation by inhibiting ROR{gamma}t activity
Int. Immunol.,
July 1, 2009;
21(7):
881 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-F. Lu and A. Rudensky
Molecular orchestration of differentiation and function of regulatory T cells
Genes & Dev.,
June 1, 2009;
23(11):
1270 - 1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Molinero, J. Yang, T. Gajewski, C. Abraham, M. A. Farrar, and M.-L. Alegre
CARMA1 Controls an Early Checkpoint in the Thymic Development of FoxP3+ Regulatory T Cells
J. Immunol.,
June 1, 2009;
182(11):
6736 - 6743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Oh, G. Blevins, C. Griffith, N. Richert, D. Maric, C. R. Lee, H. McFarland, and S. Jacobson
Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Arch Neurol,
April 1, 2009;
66(4):
471 - 479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ouaked, P.-Y. Mantel, C. Bassin, S. Burgler, K. Siegmund, C. A. Akdis, and C. B. Schmidt-Weber
Regulation of the foxp3 Gene by the Th1 Cytokines: The Role of IL-27-Induced STAT1
J. Immunol.,
January 15, 2009;
182(2):
1041 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, H. D. Edington, U. N.M. Rao, D. M. Jukic, A. Radfar, H. Wang, and J. M. Kirkwood
Effects of High-Dose IFN{alpha}2b on Regional Lymph Node Metastases of Human Melanoma: Modulation of STAT5, FOXP3, and IL-17
Clin. Cancer Res.,
December 15, 2008;
14(24):
8314 - 8320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sgouroudis, A. Albanese, and C. A. Piccirillo
Impact of Protective IL-2 Allelic Variants on CD4+Foxp3+ Regulatory T Cell Function In Situ and Resistance to Autoimmune Diabetes in NOD Mice
J. Immunol.,
November 1, 2008;
181(9):
6283 - 6292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kerenyi, F. Grebien, H. Gehart, M. Schifrer, M. Artaker, B. Kovacic, H. Beug, R. Moriggl, and E. W. Mullner
Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1
Blood,
November 1, 2008;
112(9):
3878 - 3888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Y. Wuest, J. Willette-Brown, S. K. Durum, and A. A. Hurwitz
The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
J. Leukoc. Biol.,
October 1, 2008;
84(4):
973 - 980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tsuji-Takayama, M. Suzuki, M. Yamamoto, A. Harashima, A. Okochi, T. Otani, T. Inoue, A. Sugimoto, T. Toraya, M. Takeuchi, et al.
The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus
J. Immunol.,
September 15, 2008;
181(6):
3897 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kared, B. Leforban, R. Montandon, A. Renand, E. Layseca Espinosa, L. Chatenoud, Y. Rosenstein, E. Schneider, M. Dy, and F. Zavala
Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors
Blood,
September 15, 2008;
112(6):
2575 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Vang, J. Yang, S. A. Mahmud, M. A. Burchill, A. L. Vegoe, and M. A. Farrar
IL-2, -7, and -15, but Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development
J. Immunol.,
September 1, 2008;
181(5):
3285 - 3290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhu and W. E. Paul
CD4 T cells: fates, functions, and faults
Blood,
September 1, 2008;
112(5):
1557 - 1569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kasprzycka, Q. Zhang, A. Witkiewicz, M. Marzec, M. Potoczek, X. Liu, H. Y. Wang, M. Milone, S. Basu, J. Mauger, et al.
{gamma}c-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes
J. Immunol.,
August 15, 2008;
181(4):
2506 - 2512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hosui and L. Hennighausen
Genomic dissection of the cytokine-controlled STAT5 signaling network in liver
Physiol Genomics,
July 1, 2008;
34(2):
135 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takaki, K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi
STAT6 Inhibits TGF-{beta}1-mediated Foxp3 Induction through Direct Binding to the Foxp3 Promoter, Which Is Reverted by Retinoic Acid Receptor
J. Biol. Chem.,
May 30, 2008;
283(22):
14955 - 14962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hennighausen and G. W. Robinson
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
Genes & Dev.,
March 15, 2008;
22(6):
711 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, H. Takeuchi, Y. Sonobe, S. Jin, T. Mizuno, S. Miyakawa, M. Fujiwara, Y. Nakamura, T. Kato, H. Muramatsu, et al.
Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population
PNAS,
March 11, 2008;
105(10):
3915 - 3920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Huber, V. Steinwald, A. Guralnik, A. Brustle, P. Kleemann, C. Rosenplanter, T. Decker, and M. Lohoff
IL-27 inhibits the development of regulatory T cells via STAT3
Int. Immunol.,
February 1, 2008;
20(2):
223 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Elias, A. Laurence, T. S. Davidson, G. Stephens, Y. Kanno, E. M. Shevach, and J. J. O'Shea
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway
Blood,
February 1, 2008;
111(3):
1013 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zeiser, D. B. Leveson-Gower, E. A. Zambricki, N. Kambham, A. Beilhack, J. Loh, J.-Z. Hou, and R. S. Negrin
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood,
January 1, 2008;
111(1):
453 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Davis, K. Skak, M. J. Smyth, P. E.G. Kristjansen, D. M. Miller, and P. V. Sivakumar
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity
Clin. Cancer Res.,
December 1, 2007;
13(23):
6926 - 6932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. De Luca, C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C. D'Angelo, C. Vacca, L. Boon, F. Bistoni, et al.
Functional yet Balanced Reactivity to Candida albicans Requires TRIF, MyD88, and IDO-Dependent Inhibition of Rorc
J. Immunol.,
November 1, 2007;
179(9):
5999 - 6008.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|